Moksha8
Latest round
- Series C
Last raised
- Oct 2010
Total raised
- $125M
Investors
- 5
About Moksha8
Founded in 2007 and headquartered in Sao Paulo, Brazil, Moksha8 focuses on forming collaborations with leading pharmaceutical companies. The CEO, Joel Barlan, leads the company that has not undergone significant changes in its operational strategy. Moksha8 has successfully completed 8 deals, with its most recent being a Trade Sale to Forest Laboratories, Inc.Moksha8 Pharmaceuticals specializes in forming strategic partnerships with leading pharmaceutical companies to develop and commercialize innovative medicines across various therapeutic areas, including central nervous system disorders, cardiometabolism, respiratory issues, gastroenterology, oncology and hematology, and rare diseases. Their product portfolio includes advanced therapies designed to address significant medical needs, particularly in Latin America. Notable products include Voraxaze® (Glucarpidase), utilized for treating cancer patients, and Qelbree® (Viloxazine XR), which addresses attention-deficit/hyperactivity disorder.Moksha8 Pharmaceuticals generates revenue through strategic licensing agreements and exclusive partnerships with established pharmaceutical firms, facilitating the entry of innovative treatments into the Latin American market. Transactions typically occur through B2B arrangements, where Moksha8 collaborates with its partners to bring products from regulatory approval to full commercialization. The structure of these transactions often involves upfront licensing fees, milestone payments, and royalties on product sales. to support the development of upcoming innovative products and expand its market reach. The company is set to launch new therapies across its therapeutic areas while targeting additional markets in Latin America.
Who invested in Moksha8
5 investors across 4 rounds
See all investors in Moksha8
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Moksha8
Who invested in Moksha8?
Moksha8 has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Moksha8 raised?
Moksha8 has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Moksha8 last raise money?
Moksha8's most recent round on record is a Series C, in Oct 2010.
What does Moksha8 do?
Founded in 2007 and headquartered in Sao Paulo, Brazil, Moksha8 focuses on forming collaborations with leading pharmaceutical companies.
Where is Moksha8 headquartered?
Moksha8 is headquartered in Sao Paulo, Brazil.
Which VCs invest in companies like Moksha8?
Among active investors with capital left to deploy, Crescera Capital, Apex Group, Kaszek Ventures and TMF Group back pharmaceuticals companies at Moksha8's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Moksha8? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.